Circulating tumor DNA (ctDNA) in fluids has gained attention because ctDNA seems to
identify tumor-specific abnormalities, which could be used for diagnosis, follow-up of …

Extracellular vesicles (EVs) mediate intercellular signaling and communication, allowing the
intercellular exchange of proteins, lipids, and genetic material. Their recognized role in the …

Results Overall, 447 665 new cases of pancreatic cancer were recorded around the world in
2017 (58.6 per million), with global prevalence of 49.8 per million and 441 083 deaths (57.7 …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies. Tumor-
derived extracellular vesicles (EVs) induce pre-metastatic niche formation to promote …

The role of long noncoding RNAs (lncRNAs) in the epithelial‐mesenchymal transition (EMT)
in pancreatic ductal adenocarcinoma (PDAC) is unclear. Some lncRNAs can be transferred …

Extracellular vesicles (EVs) are small membraned vesicles and approximately 50–150 nm in
diameter. Almost all of the type of cells releases the EVs and circulates in the body fluids …

Precision medicine has impacted the field of medical oncology by introducing personalized
therapies, improving all measurable outcomes. This field, in turn, has expanded to obtaining …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is one of the tumors with the
highest mortality, for which survival has hardly changed in the last 40 years. This high …

Pancreatic cancer is a challenging disease with a low 5-year survival rate. There are areas
for improvement in the tools used for screening, diagnosis, prognosis, treatment selection …

Precision oncology aims to tailor clinical decisions specifically to patients with the objective
of improving treatment outcomes. This can be achieved by leveraging omics information for …